Additional file 14 of Targeting PRMT5 alleviates diabetic cardiomyopathy: mechanisms involve Ndufs2 R118 dimethylation-mediated complex I protection and serum PRMT5 as a biomarker
- DOI
- 10.6084/m9.figshare.34965026.v1
- Published
- 2026
- Container
- Not recorded
- Publisher
- figshare
- Open access
- yes
Credibility signals
limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.6084/m9.figshare.34965026.v1,
title = {Additional file 14 of Targeting PRMT5 alleviates diabetic cardiomyopathy: mechanisms involve Ndufs2 R118 dimethylation-mediated complex I protection and serum PRMT5 as a biomarker},
author = {Sidong Cai and Mengqi Su and Jing Li and Yang Yu and Min Wu and Mingya Liu and Run Wang and Jie Huang and Qingxia Lai and Cong Chen and Kai-Hang Yiu},
year = {2026},
doi = {10.6084/m9.figshare.34965026.v1},
url = {https://doi.org/10.6084/m9.figshare.34965026.v1}
}RIS
TY - JOUR TI - Additional file 14 of Targeting PRMT5 alleviates diabetic cardiomyopathy: mechanisms involve Ndufs2 R118 dimethylation-mediated complex I protection and serum PRMT5 as a biomarker AU - Sidong Cai AU - Mengqi Su AU - Jing Li AU - Yang Yu AU - Min Wu AU - Mingya Liu AU - Run Wang AU - Jie Huang AU - Qingxia Lai AU - Cong Chen AU - Kai-Hang Yiu PY - 2026 DO - 10.6084/m9.figshare.34965026.v1 UR - https://doi.org/10.6084/m9.figshare.34965026.v1 ER -
APA
Cai, S., Su, M., Li, J., Yu, Y., Wu, M., Liu, M., Wang, R., Huang, J., Lai, Q., Chen, C., & Yiu, K. (2026). Additional file 14 of Targeting PRMT5 alleviates diabetic cardiomyopathy: mechanisms involve Ndufs2 R118 dimethylation-mediated complex I protection and serum PRMT5 as a biomarker. https://doi.org/10.6084/m9.figshare.34965026.v1
Source records
- datacite · retrieved 2026-11-10T11:03:31.411Z